Financial Performance - Total revenue for the fiscal year ended December 31, 2019, was HKD 164,209,000, a decrease of 2.1% compared to HKD 168,905,000 in 2018[10] - The pre-tax loss for 2019 was HKD 1,942,000, an improvement from a loss of HKD 6,926,000 in 2018[10] - The net loss for the year was HKD 1,942,000, compared to a net loss of HKD 6,926,000 in the previous year, indicating a significant reduction in losses[10] - The group's revenue decreased from approximately HKD 168.9 million in 2018 to HKD 164.2 million in 2019, a decline of 2.8%[26] - The company’s financial performance and status as of December 31, 2019, are detailed in the consolidated financial statements[171] Assets and Liabilities - Total assets as of December 31, 2019, were HKD 105,941,000, a decrease from HKD 113,539,000 in 2018[11] - Total liabilities decreased to HKD 53,840,000 in 2019 from HKD 59,128,000 in 2018, reflecting improved financial stability[11] - As of December 31, 2019, the group's net asset value was approximately HKD 52.1 million, down from HKD 54.4 million in 2018[34] - Current assets were approximately HKD 92.5 million as of December 31, 2019, compared to HKD 98.6 million in 2018[37] Revenue Sources and Sales - Transformers continued to be the best-selling product, accounting for approximately 55.0% of total sales for the fiscal year[16] - New electronic health products, including electric toothbrushes, contributed approximately 9.2% to total sales, marking a new sustainable product line[16] - The sales percentage of switching power supplies was about 1.2%, slightly up from 1.1% in 2018[16] - The company focused on consolidating relationships with existing customers, resulting in a slight decline in revenue compared to the previous year[16] - The company’s revenue decreased by 2.8% due to a decline in sales to US customers and Hong Kong trading entities during the trade war[131] Cost and Profitability - Gross profit increased by approximately HKD 1.8 million or 7.3%, from about HKD 24.8 million in 2018 to approximately HKD 26.6 million in 2019, with a gross margin rise from 14.7% to 16.2%[26] - Sales and distribution expenses decreased by approximately HKD 0.5 million or 7.0%, from about HKD 6.7 million in 2018 to approximately HKD 6.2 million in 2019[29] - Administrative expenses decreased by approximately HKD 2.5 million or 10.4%, from about HKD 24.2 million in 2018 to approximately HKD 21.7 million in 2019[30] Business Strategy and Opportunities - The group is exploring new business opportunities to diversify revenue sources, particularly in construction projects in Hong Kong[26] - The group expects an increase in sales of inverters and chargers in the coming year, along with progress in upgrading electronic health products[33] - The company plans to enhance competitiveness by continuously developing new products and upgrading technology and machinery to improve production capacity and efficiency[131] - The company has established online sales channels and marketing activities to promote new products and maintain customer relationships[131] Corporate Governance - The board consists of six directors, including three executive directors and three independent non-executive directors[71] - The company has complied with the corporate governance code during the year ended December 31, 2019[69] - The board held four meetings during the year, with all executive directors attending all meetings[75][76] - The company has established an audit committee to assist the board in overseeing financial reporting, internal controls, and risk management, which held four meetings in the fiscal year ending December 31, 2019[91] - The company has adopted a code of conduct for securities trading that is less stringent than the GEM Listing Rules[70] Risk Management - The company has established a risk management and internal control system, which was reviewed and deemed sufficient and effective as of December 31, 2019[148] - The company emphasizes the importance of maintaining an effective risk management system for achieving business objectives and sustainable growth[120] - The company has engaged an independent internal control consultant to review its risk management and internal control systems[111] - The risk management committee held one meeting during the year ended December 31, 2019, to review risk management policies and internal controls[111] Employee and Management - The total employee cost for the year ended December 31, 2019, was approximately HKD 33.4 million, down from HKD 35.5 million in 2018[45] - The company has conducted regular training for employees on quality control and production facility operations to mitigate operational risks[144] - The company has established a governance framework that includes the audit committee, remuneration committee, nomination committee, and risk management committee to support board functions[86] Shareholder Communication and Dividends - The company aims to provide high levels of disclosure and financial transparency to shareholders and investors through quarterly, interim, and annual reports[152] - The board of directors does not intend to declare a final dividend for the fiscal year ending December 31, 2019[172] - The company has adopted a dividend policy to maintain sufficient cash reserves for operational needs and future business growth[173] - The company encourages shareholders to attend the annual general meeting and provides at least 20 business days' notice[152]

Financial Performance - The company's revenue for the nine months ended September 30, 2019, was approximately HKD 124.54 million, a decrease of about HKD 2.45 million or 1.93% compared to HKD 126.99 million for the same period in 2018[16] - The gross profit for the nine months ended September 30, 2019, was approximately HKD 20.07 million, an increase of about HKD 2.74 million or 15.81% from HKD 17.33 million in the same period of 2018[16] - The company recorded a loss of approximately HKD 2.52 million for the nine months ended September 30, 2019, compared to a restated loss of approximately HKD 6.75 million for the same period in 2018[20] - Basic and diluted loss per share for the nine months ended September 30, 2019, was HKD 1.26, compared to HKD 3.37 for the same period in 2018[23] - For the nine months ended September 30, 2019, the pre-tax loss was HKD 2,523,000, a significant improvement from a loss of HKD 6,751,000 in the same period of 2018, indicating a reduction of 62.7%[49] Sales and Product Performance - The sales of transformers accounted for approximately 46.35% of total sales for the nine months ended September 30, 2019, down from 56.00% in the same period of 2018[9] - The sales percentage of switching power supplies increased to approximately 9.92% for the nine months ended September 30, 2019, compared to 1.17% in the same period of 2018[9] - The new electronic healthcare product line accounted for approximately 9.96% of total sales for the nine months ended September 30, 2019, compared to no sales in the same period of 2018[9] - Sales of transformers decreased to HKD 57,722,000 for the nine months ended September 30, 2019, down 18.8% from HKD 71,113,000 in 2018[38] - Sales of switching power supplies increased significantly to HKD 12,349,000 for the nine months ended September 30, 2019, compared to HKD 1,481,000 in 2018, representing an increase of 733.5%[38] Cost Management - The sales cost decreased by approximately HKD 5.19 million or 4.73% to about HKD 104.48 million for the nine months ended September 30, 2019, from HKD 109.66 million in the same period of 2018[16] - Sales and distribution expenses decreased by approximately HKD 260,000 or 5.05% to about HKD 4.89 million for the nine months ended September 30, 2019, mainly due to reduced freight and handling fees[19] - Administrative expenses decreased by approximately HKD 1.45 million or 7.90% to about HKD 16.91 million for the nine months ended September 30, 2019, due to streamlined administrative workflows[19] - Financing costs slightly decreased by approximately HKD 170,000 or 11.26% to about HKD 1.34 million for the nine months ended September 30, 2019, attributed to lower interest on lease liabilities[20] - Research and development expenses for the nine months ended September 30, 2019, were HKD 1,992,000, down from HKD 2,505,000 in 2018, marking a decrease of 20.4%[45] Market Outlook and Strategy - The company remains cautiously optimistic about market prospects despite global economic uncertainties and political instability[10] - The company is optimistic about the progress of US-China trade negotiations and plans to actively explore transformer markets in other regions to mitigate risks associated with the US market[21] - The company aims to enhance production efficiency and reduce costs while promoting existing products and expanding overseas markets[21] Other Financial Information - Other income decreased by approximately HKD 325,000 or 50.98% to about HKD 338,000 for the nine months ended September 30, 2019, primarily due to reduced bank interest income and lower waste sales[17] - The company reported a total tax expense of HKD 200,000 for the nine months ended September 30, 2019, compared to no tax expense in the same period of 2018[46] - The total other income for the three months ended September 30, 2019, was HKD 59,000, compared to HKD 201,000 in 2018, indicating a decrease of 70.6%[42] Corporate Governance - The audit committee was established on February 2, 2016, and currently consists of three independent non-executive directors[67] - The company has complied with the corporate governance code during the nine months ended September 30, 2019[70] - There were no arrangements that caused directors or senior management to hold any interests in the company's shares or related securities during the period from January 1, 2019, to September 30, 2019[61] - The company has adopted a code of conduct for directors regarding securities trading, which is more lenient than the GEM Listing Rules[63] - There were no competitive businesses or conflicts of interest reported by directors or controlling shareholders during the nine months ended September 30, 2019[65]

Revenue and Sales Performance - The group's revenue for the six months ended June 30, 2019, showed a moderate growth compared to the same period last year, driven by the sales of new electronic health products[12]. - The group reported a decrease in sales of other electronic components during the review period compared to the same period in 2018[12]. - The group's revenue increased by approximately HKD 7.53 million or 9.26%, from approximately HKD 81.36 million for the six months ended June 30, 2018, to approximately HKD 88.89 million for the six months ended June 30, 2019[17]. - Total revenue for the six months ended June 30, 2019, was HKD 88,888,000, an increase of 9.3% from HKD 81,362,000 in the same period of 2018[56]. - Sales of transformers decreased to HKD 39,166,000 for the six months ended June 30, 2019, down from HKD 44,040,000 in 2018, representing a decline of 11.7%[56]. - Sales of electronic health products reached HKD 9,110,000 for the six months ended June 30, 2019, with no sales recorded in the same period of 2018, indicating a new revenue stream[56]. Profitability and Financial Metrics - Gross profit rose by approximately HKD 3.39 million or 29.95%, from approximately HKD 11.32 million to approximately HKD 14.71 million, with the gross profit margin increasing from 13.91% to 16.55%[17]. - The group recorded a loss of approximately HKD 0.37 million for the six months ended June 30, 2019, compared to a loss of approximately HKD 4.32 million for the same period in 2018[21]. - The company recognized a total of HKD 200,000 in tax expenses for the six months ended June 30, 2019, compared to no tax expenses in the same period of 2018, indicating a shift towards profitability[59]. - The company reported a loss attributable to owners of the company of HKD 371,000 for the six months ended June 30, 2019, compared to a loss of HKD 4,338,000 for the same period in 2018, representing a 91.4% improvement[63]. Expenses and Cost Management - Administrative expenses decreased by approximately HKD 0.87 million or 7.16%, from approximately HKD 12.15 million to approximately HKD 11.28 million, due to streamlined administrative processes[20]. - Financing costs slightly decreased by approximately HKD 0.10 million or 9.90%, from approximately HKD 1.01 million to approximately HKD 0.91 million, attributed to a reduction in bank loans[21]. - The cost of goods sold for the six months ended June 30, 2019, was HKD 53,751,000, down 20.9% from HKD 67,859,000 in 2018[5]. - Research and development expenses decreased to HKD 1,325,000 for the six months ended June 30, 2019, from HKD 1,547,000 in 2018, a reduction of 14.4%[5]. Assets and Liabilities - As of June 30, 2019, the group's net asset value was approximately HKD 54.15 million, a slight decrease from approximately HKD 54.41 million as of December 31, 2018[25]. - The total assets as of June 30, 2019, amounted to HKD 105.175 million, compared to HKD 98.586 million at the end of 2018[43]. - The inventory level decreased to HKD 50.039 million as of June 30, 2019, from HKD 52.115 million at the end of 2018[43]. - Trade receivables increased to HKD 38,119,000 as of June 30, 2019, compared to HKD 28,878,000 as of December 31, 2018, reflecting a 32.1% increase[67]. - Trade payables rose to HKD 29,906,000 as of June 30, 2019, from HKD 19,678,000 as of December 31, 2018, indicating a 51.9% increase[68]. Cash Flow and Financing Activities - For the six months ended June 30, 2019, the net cash used in operating activities was HKD (3,876,000), compared to HKD (2,865,000) for the same period in 2018, indicating a decline in cash flow from operations[47]. - The net cash used in investing activities was HKD (2,432,000) for the six months ended June 30, 2019, compared to a net cash inflow of HKD 1,822,000 in 2018, reflecting a significant change in investment strategy[47]. - The net cash generated from financing activities was HKD 3,190,000 for the six months ended June 30, 2019, compared to a net cash outflow of HKD (1,522,000) in 2018, showing improved financing conditions[47]. Corporate Governance and Compliance - The company has adopted the principles and code provisions of the corporate governance code as set out in the GEM Listing Rules to ensure proper regulation of its operations and decision-making processes[100]. - The company has complied with the corporate governance code from January 1, 2019, to June 30, 2019[101]. - The audit committee, formed on February 2, 2016, currently consists of three independent non-executive directors, with the chairman being Mr. Ng Wing Cheung[97]. - The company is focused on maintaining transparency and adherence to governance standards[101]. Future Outlook and Strategic Plans - The company plans to enhance production efficiency and reduce costs while expanding its product range and exploring overseas markets[24]. - The company continues to prioritize corporate governance as a key strategy[101]. - No new products, technologies, market expansions, or acquisitions were mentioned in the provided content[101][102].

Revenue and Sales Performance - The group's revenue increased by approximately HKD 4.61 million or 12.02%, from about HKD 38.36 million for the three months ended March 31, 2018, to about HKD 42.97 million for the three months ended March 31, 2019[16]. - Revenue for the three months ended March 31, 2019, was approximately HKD 42,972, an increase from HKD 38,361 in the same period of 2018, representing a growth of about 4.20%[24]. - The group's revenue for the three months ended March 31, 2019, was HKD 42,972,000, an increase of 12.0% compared to HKD 38,361,000 for the same period in 2018[34]. - Transformer sales contributed HKD 21,672,000, up 13.3% from HKD 19,134,000 in 2018, while electronic health product sales were HKD 5,212,000, a new addition to the revenue stream[34]. - Revenue from external customers in China was HKD 12,717,000, down 9.4% from HKD 14,045,000 in 2018, while Europe saw an increase to HKD 13,441,000 from HKD 8,945,000[37]. Profitability and Gross Margin - Gross profit increased by approximately HKD 3.83 million or 73.23%, from about HKD 5.23 million for the three months ended March 31, 2018, to about HKD 9.06 million for the same period in 2019[16]. - The gross profit margin rose from 13.63% for the three months ended March 31, 2018, to 21.08% for the same period in 2019[16]. - The company recorded a profit of approximately HKD 1.45 million for the three months ended March 31, 2019, compared to a loss of about HKD 2.73 million in the same period of 2018[20]. - The group reported a pre-tax profit of HKD 1,445,000 for the three months ended March 31, 2019, compared to a loss of HKD 2,727,000 in the same period of 2018[49]. Expenses and Cost Management - Sales and distribution expenses decreased by approximately HKD 260,000 or 14.44% to about HKD 1.54 million for the three months ended March 31, 2019, mainly due to reduced freight and handling fees[19]. - Administrative expenses decreased by approximately HKD 340,000 or 5.71% to about HKD 5.61 million for the three months ended March 31, 2019, due to streamlined administrative processes[19]. - The group decided to suspend the production and sale of enameled copper wire due to low profit margins, allowing resources to be allocated to more profitable products[11]. - The group incurred research and development expenses of HKD 708,000, slightly down from HKD 738,000 in 2018[44]. Product Performance - Transformer products accounted for approximately 50.43% of the group's sales for the three months ended March 31, 2019, compared to 49.88% for the same period in 2018[10]. - The new electronic health product line contributed approximately HKD 5.21 million to sales, representing about 12.13% of total sales for the three months ended March 31, 2019[10]. - The sales percentage of switching power supplies was approximately 1.09% for the three months ended March 31, 2019, down from 1.25% for the same period in 2018[10]. - The sales percentage of other electronic components decreased to approximately 36.35% for the three months ended March 31, 2019, from 48.88% for the same period in 2018[10]. Cash Flow and Financial Position - The group's cash flow situation improved due to reduced resource allocation for raw materials[12]. - Total employee costs, including directors' remuneration, were HKD 2,945,000, an increase of 6.4% from HKD 2,769,000 in 2018[44]. - The group's bank interest income decreased to HKD 22,000 from HKD 61,000 in 2018, a decline of 63.6%[39]. - The group's total revenue from other sources was HKD 31,000, down from HKD 85,000 in 2018, indicating a decrease of 63.5%[39]. Future Outlook and Strategy - The company plans to expand its product range and improve production efficiency to reduce costs while promoting existing products and exploring overseas markets[21]. - The company expects a favorable outlook for electronic health products in the European market and aims to manufacture more similar products to meet rising demand[21]. Tax and Earnings - The income tax expense increased by approximately HKD 200,000 or 100% to HKD 200,000 for the three months ended March 31, 2019, due to profit recorded during the review period[20]. - Basic earnings per share improved to HKD 0.72 for the three months ended March 31, 2019, compared to a loss of HKD 1.36 in the same period of 2018[24]. Dividends and Corporate Governance - The group did not declare an interim dividend for the three months ended March 31, 2019, consistent with the previous year[48]. - No dividends were recommended for the three months ended March 31, 2019, consistent with the previous year[57]. - The audit committee reviewed the unaudited condensed consolidated financial results for the three months ended March 31, 2019, and found no disagreement with the accounting treatment adopted by the company[64]. - The company has complied with the corporate governance code during the period from January 1, 2019, to March 31, 2019[68].

Financial Performance - For the fiscal year ended December 31, 2018, the company's revenue was HKD 168.905 million, a decrease of 2.1% compared to HKD 173.993 million in 2017[10]. - The company reported a loss before tax of HKD 6.881 million for 2018, compared to a loss of HKD 6.737 million in 2017, indicating a worsening financial performance[10]. - Total assets as of December 31, 2018, were HKD 108.930 million, a decrease of 1.4% from HKD 110.495 million in 2017[11]. - Total liabilities increased to HKD 54.335 million in 2018, up from HKD 49.403 million in 2017, reflecting a rise of 10.4%[11]. - The group recorded a loss of approximately 6.9 million HKD for the year, slightly higher than the previous year's loss of 6.7 million HKD[26]. - The gross profit decreased by approximately 4.8 million HKD or 16.4%, resulting in a gross profit margin decline from 19.0% to 14.5% due to rising material costs[22]. - The group maintained a stable liquidity level, with bad debt provisions totaling HKD 2.8 million as of December 31, 2018, unchanged from the previous year[108]. Revenue and Sales - The company's best-selling product, transformers, accounted for approximately 54.4% of total sales for the fiscal year ended December 31, 2018, up from 53.4% in 2017[15]. - The group's revenue for the year increased by approximately 14.9 million HKD or 9.7%, reaching about 168.9 million HKD, primarily driven by product price adjustments and sales from new products[22]. - Sales of new products, including electric toothbrushes and inverters, contributed approximately 6.8 million HKD in revenue in 2018[16]. - The company's revenue increased by 9.7% in 2018, attributed to stable sales growth of newly developed products such as electronic health products and inverters[104]. - The top five customers accounted for about 47.9% of the company's revenue in 2018, up from 47.2% in 2017, indicating a high dependency on a limited customer base[105]. Product Development and Market Strategy - The company plans to continue research and development on existing and new products, focusing on both domestic and overseas markets in 2019[13]. - The company plans to continue developing new products and expanding its product range to enhance capacity and strengthen customer relationships[28]. - New products are expected to continue contributing to sales in the coming year, leveraging unique designs and functionalities in the market[27]. - The company established online sales channels and launched new products to enhance market presence and customer engagement[104]. Cost Management and Expenses - Sales expenses decreased by approximately 0.3 million HKD or 4.3%, attributed to changes in reimbursement policies for sales-related expenses[25]. - Administrative expenses decreased by approximately 4.6 million HKD or 16.0%, due to successful cost-cutting measures[25]. - The total employee cost for the year ended December 31, 2018, was approximately HKD 35.5 million, slightly up from HKD 35.4 million in the previous year, showing a marginal increase of about 0.3%[37]. Risk Management and Compliance - The company has established a risk management and internal control system, confirmed by senior management[60]. - The risk management framework includes identifying, analyzing, rating, and prioritizing risks, as well as developing action plans and detailed monitoring procedures[101]. - The company has identified four categories of risks: strategic, financial, operational, and compliance, with senior management responsible for risk identification[103]. - The audit committee supports the board in reviewing the design, implementation, and monitoring of the risk management and internal control framework, providing independent opinions annually[98]. - The company emphasizes the importance of maintaining an effective risk management and internal control system for achieving business objectives and sustainable growth[96]. Corporate Governance - The company has complied with the corporate governance code for the year ending December 31, 2018[54]. - The board consists of six members, including three executive directors and three independent non-executive directors[56]. - The company has three independent non-executive directors, meeting the requirements of the GEM Listing Rules[63]. - The chairman and CEO roles are separated, with the chairman responsible for business development and strategy formulation[66]. - The company has adopted a code of conduct for securities trading that is less stringent than the GEM Listing Rules[55]. Shareholder Communication and Transparency - The company aims to provide high levels of disclosure and financial transparency to shareholders and investors[118]. - The board of directors attended the annual general meeting to address shareholder inquiries[118]. - The company has established multiple communication channels with shareholders, including quarterly and annual reports[118]. - The company encourages shareholders to attend the annual general meeting and provides at least 20 business days' notice[118]. Stock Option Plan - The company has established a share option scheme approved by shareholders on February 2, 2016, in accordance with GEM listing rules[157]. - The stock option plan aims to incentivize eligible participants to enhance performance efficiency and retain talent beneficial for the company's long-term development[160]. - The total number of stock options that can be granted under the plan is subject to adjustments based on changes in the company's capital structure[161]. - The company must ensure compliance with GEM listing rules when granting stock options to connected persons[165]. - As of December 31, 2018, the company had no stock options granted, exercised, canceled, or expired under the stock option plan[188].